Invention Grant
- Patent Title: 3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
-
Application No.: US16716662Application Date: 2019-12-17
-
Publication No.: US11491156B2Publication Date: 2022-11-08
- Inventor: Sheila DeWitt
- Applicant: DeuteRx, LLC
- Applicant Address: US MA Andover
- Assignee: DeuteRx, LLC
- Current Assignee: DeuteRx, LLC
- Current Assignee Address: US MA Andover
- Agency: Goodwin Procter LLP
- Main IPC: C07D401/04
- IPC: C07D401/04 ; A61K31/517 ; A61K9/00
Abstract:
The invention provides 3-deuterium-enriched 3-(6-, 7-, or 8-substituted-4-oxoquinazolin-3(4H)-yl)-piperidine-2,6-diones, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treatment using the same.
Information query
